BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Friday reported a loss of $36.6 million in its second quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 64 cents. Losses, adjusted for non-recurring costs, were 34 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The biotechnology company posted revenue of $1.6 million in the period.
Ocular Therapeutix shares have more than doubled since the beginning of the year. The stock has increased 82% in the last 12 months.